Q32 Bio Inc.QTTBNASDAQ
LOADING
|||
Cash Flow Under Pressure
Trending lower, below historical average, strong compound growth.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-67.79M
↓ 23% below average
Average (8y)
$-55.20M
Historical baseline
Range
High:$4.52M
Low:$-113.19M
CAGR
+26.3%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-67.79M | -262.9% |
| 2023 | $-18.68M | -39.0% |
| 2022 | $-13.44M | +88.0% |
| 2021 | $-112.15M | -14.4% |
| 2020 | $-98.06M | +13.4% |
| 2019 | $-113.19M | -67.7% |
| 2018 | $-67.50M | -1593.1% |
| 2017 | $4.52M | +143.2% |
| 2016 | $-10.47M | - |